UK regulator says trial of HCQ for Covid-19 can resume

The Medicines and Healthcare Products Regulatory Agency’s decision on the trial comes after the drug was found in another UK trial to have no benefit for patients already infected with Covid-19.

from Hindustan Times - world https://bit.ly/2NLdyi4
https://ift.tt/2zbki14